Comparison of Toxicities Associated with Concomitant Boost and Conventional Fractionated Radiotherapy Regimen in Oral and Oropharyngeal Cancers

Comparison of Toxicities Associated with Concomitant Boost and Conventional Fractionated Radiotherapy Regimen in Oral and Oropharyngeal Cancers

Introduction: The prevalence of Head and Neck Cancers (HNC) is very high in the Indian subcontinent. Radiotherapy is an essential modality in the management of HNC. Aim: The aim of the present study was to compare toxicities of two radiotherapy fractionation regimen (conventional fractionation and...

Full description

Bibliographic Details
Main Authors:	Abhishek Shrivastava, Hameeduzzafar Ghori, Omprakash Singh, Vivek Tiwari, Veenita Yogi, Ramsingh Jamre, Varsha Mandloi
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2017-10-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	Fractionation Head and neck cancers Morbidity Radiotherapy
Online Access:	http://jcdr.net/articles/PDF/10692/30115_CE(Ra1)_F(SS)PF1-(PrG_VJ_PY)_PFA(VJ_AP).pdf

Similar Items

Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
by: Adity Chakraborty, et al.
Published: (2021-06-01)

Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy
by: Beat Bojaxhiu, et al.
Published: (2020-12-01)

The patient-reported outcome measures in oropharyngeal, laryngeal and hypopharyngeal cancer patients treated with Volumetric Modulated Arc based simultaneous integrated boost radiotherapy
by: Thiraviyam Elumalai, et al.
Published: (2021-06-01)

Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
by: Prashant Vempati, et al.
Published: (2020-12-01)

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands
by: Maximilian P. Schmid, et al.
Published: (2021-01-01)

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
by: Jensen Alexandra D, et al.
Published: (2012-04-01)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
by: Alexandre Arthur Jacinto, et al.
Published: (2018-10-01)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
by: Michael Laursen, et al.
Published: (2018-06-01)

Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review
by: Jerome R. Lechien, et al.
Published: (2019-09-01)

Postoperative radiotherapy is associated with improved survival in pT1-2N1 oral and oropharyngeal cancer without adequate neck dissection
by: Ching-Chieh Yang, et al.
Published: (2021-01-01)

Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
by: Lee Dong, et al.
Published: (2012-06-01)

Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer
by: Cédric Panje, et al.
Published: (2017-09-01)

CHARACTERISTICS OF PATIENTS TREATED IN A HEAD AND NECK CANCER SURGERY AMBULATORY IN BAHIA
by: Jéssica Fernandes Santos, et al.
Published: (2016-07-01)

Comparison of Acute and Late toxicity of two regimens of 3- and 5-Week Concomitant Boost IMRT to Standard 6-Week Breast Radiotherapy
by: Shahzad eRaza, et al.
Published: (2012-05-01)

Comparative Study of the Perioperative Care of Head and Neck Surgical Patients with and without Central Venous Pressure Line
by: Amjad Ali
Published: (2012-12-01)

Representation to the accident and emergency department within 1-year of a fractured neck of femur
by: Bryson David J, et al.
Published: (2011-12-01)

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
by: Retèl Valesca P, et al.
Published: (2011-11-01)

Oropharyngeal cancer: an emergent disease?
by: Martín Granados-García
Published: (2016-03-01)

Impact of oral hygiene on the development of oropharyngeal neoplasms
by: D. G. Kiparisova, et al.
Published: (2015-06-01)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
by: Marcus Wurlitzer, et al.
Published: (2020-06-01)

Endometrial Adenocarcinoma with Concomitant Left Atrial Myxoma
by: Lisa N. Abaid, et al.
Published: (2009-08-01)

Psychiatric and Medical Co-morbidities among the substance abusers presenting at Patna Medical college- A clinical study
by: Vivek Pratap Singh, et al.
Published: (2021-09-01)

Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-Pandemic
by: Philippe Gorphe, et al.
Published: (2021-03-01)

Hyponatremia caused by water intoxication and malnutrition in a patient with metastatic oropharyngeal carcinoma
by: Marin Prpić, et al.
Published: (2017-06-01)

The Cost of Treating Human Papillomavirus-Related Oropharyngeal Cancer
by: Houston, Karla Smalley
Published: (2019)

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers
by: Paul Giraud, et al.
Published: (2021-12-01)

Advanced Oropharyngeal Cancer Can Be Easily Missed During Esophagogastroduodenoscopy
by: Kenta Hamada, et al.
Published: (2017-05-01)

Assessment of periodontal changes in patients undergoing radiotherapy for head-and-neck malignancy
by: Gaurav Sharma, et al.
Published: (2020-01-01)

Development of a Novel Psycho-biological Tool for the Measurement of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Concomitant Chemotherapy
by: Gussgard, Anne Margrete
Published: (2012)

Development of a Novel Psycho-biological Tool for the Measurement of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Concomitant Chemotherapy
by: Gussgard, Anne Margrete
Published: (2012)

Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
by: Anthony C. Nichols, et al.
Published: (2020-02-01)

A comparative evaluation of neoadjuvant chemotherapy followed by concomitant chemoradiation versus accelerated radiation therapy versus conventional radiation therapy in a locally advanced head and neck carcinoma
by: Garima Malik, et al.
Published: (2017-01-01)

HPV-Related Oropharyngeal Cancer and Biomarkers Based on Epigenetics and Microbiome Profile
by: Spyridon Gougousis, et al.
Published: (2021-01-01)

COMPARATIVE ASSESSMENT OF CONCOMITANT INHALATIONAL ANESTHESIA MODES IN THE SURGICAL TREATMENT OF MORBID OBESITY
by: M. I. Neimark, et al.
Published: (2017-11-01)

Association of the mir-499 polymorphisms with oral cavity and oropharyngeal squamous cell carcinoma in an Iranian population
by: Atefeh Akhani, et al.
Published: (2020-01-01)

Multimodal images registration constrained by rigid structures with applications in radiotherapy
by: du Bois d'Aische, Aloys
Published: (2005)

End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma
by: Whitney Sumner, et al.
Published: (2021-08-01)

A Mouse Model of Oropharyngeal Papillomavirus-Induced Neoplasia Using Novel Tools for Infection and Nasal Anesthesia
by: Andrea Bilger, et al.
Published: (2020-04-01)

Update on oral and oropharyngeal cancer staging – International perspectives
by: Masanari G. Kato, et al.
Published: (2020-03-01)

Complications of head and neck radiotherapy: A dental perspective
by: Dale Buchanan Glynn, et al.
Published: (2019-01-01)